Semaglutide, also known by the brand names Wegovy and Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to lower blood sugar levels, weight loss, and to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart disease
Never share injection devices or needles with another person, even if the needle is changed
The tirzepatide molecules are more diluted, spread across more solvent
Temporary subsidies imposed by the Centers for Medicare & Medicaid Services (CMS) through the agencys new premium stabilization program will increase spending by $5 billion in 2025
Based on available clinical trial data and FDA labeling, there is no established direct causal link between tirzepatide and osteoporosis